Cadila Healthcare is currently trading at Rs. 413.40, up by 17.10 points or 4.31% from its previous closing of Rs. 396.30 on the BSE.
The scrip opened at Rs. 409.90 and has touched a high and low of Rs. 418.20 and Rs. 398.40 respectively. So far 216514 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 558.00 on 12-Jun-2017 and a 52 week low of Rs. 356.30 on 16-Feb-2017.
Last one week high and low of the scrip stood at Rs. 423.45 and Rs. 373.05 respectively. The current market cap of the company is Rs. 41794.29 crore.
The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 16.93% and 8.28% respectively.
The company has reported around 14-fold jump in its net profit at Rs 306.40 crore for third quarter ended December 31, 2017, as compared to Rs 22 crore for the same quarter in the previous year. Total income of the company increased by 97.87% to Rs 1631.80 crore for Q3FY18 as compared Rs 824.70 crore for the corresponding quarter previous year.
On consolidate basis, the company has reported 67.74% rise in its net profit after taxes, Non-Controlling Interests and Share of Profits of Joint Ventures at Rs 543.30 crore for the quarter ended December 31, 2017 as compared to Rs 323.90 crore for the corresponding quarter in the FY17. Total consolidated income of the company increased by 38.66% at Rs 3300.70 crore for quarter under review as compared to Rs 2380.40 crore for the same quarter ended previous year.
